Elevance Health Operating revenue - total increased by 0.4% to $49.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $48.77B to $49.49B. Over 4 years (FY 2021 to FY 2025), Operating revenue - total shows an upward trend with a 9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth suggests successful diversification into ancillary healthcare services, whereas a decline may indicate weakness in service-based business lines.
Includes all revenue streams generated from operations outside of core insurance premiums, such as pharmacy benefit mana...
Varies significantly based on the degree of vertical integration and service diversification among peers.
other_operating_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.28B | $35.55B | $36.02B | $37.89B | $38.48B | $39.63B | $39.67B | $41.90B | $43.38B | $42.48B | $42.45B | $42.27B | $43.22B | $44.72B | $44.99B | $48.77B | $49.42B | $50.09B | $49.31B | $49.49B |
| QoQ Change | — | +6.8% | +1.3% | +5.2% | +1.6% | +3.0% | +0.1% | +5.6% | +3.5% | -2.1% | -0.1% | -0.4% | +2.2% | +3.5% | +0.6% | +8.4% | +1.3% | +1.3% | -1.5% | +0.4% |
| YoY Change | — | — | — | — | +15.6% | +11.5% | +10.1% | +10.6% | +12.7% | +7.2% | +7.0% | +0.9% | -0.4% | +5.3% | +6.0% | +15.4% | +14.3% | +12.0% | +9.6% | +1.5% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Health Benefits Segment | $37.16B | $38.28B | $37.58B | $41.43B | $41.58B | $42.25B | $41.84B | $42.49B |
| CarelonRx Segment | $8.77B | $9.14B | $9.98B | $10.12B | $10.64B | $11.00B | $11.64B | $10.60B |
| Carelon Services Segment | $4.55B | $4.64B | $4.77B | $6.54B | $7.44B | $7.32B | $7.02B | $7.37B |
| Corporate & Other | — | — | — | $165.00M | $232.00M | $149.00M | — | $4.00M |
| Total | $43.22B | $44.72B | $44.99B | $48.77B | $49.42B | $50.09B | $49.31B | $49.49B |
Carelon Total, Corporate & Other Segment, Segment Eliminations were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '25 |
|---|---|
| Reportable Segments | $48.77B |
| Total | $48.77B |